Igyxos Biotherapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
Igyxos Biotherapeutics General Information
Description
Developer of pharmaceuticals and medical technologies designed to address the growing global need for improved infertility solutions for both men and women. The company specializes in identifying monoclonal antibodies that bind to and enhance the activity of gonadotropins, and hormones involved in effective reproduction, helping patients to significantly improve their activity for fertility treatments.
Contact Information
Website
www.igyxos.comCorporate Office
- Centre INRA Val de Loire
- Site de Tours
- 37380 Nouzilly
- France
Corporate Office
- Centre INRA Val de Loire
- Site de Tours
- 37380 Nouzilly
- France
Igyxos Biotherapeutics Timeline
Igyxos Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Oct-2023 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 24-Jun-2021 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 30-Jun-2020 | $1.8M | $10.3M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 21-Mar-2019 | $8.49M | $8.49M | Completed | Pre-Clinical Trials |
Igyxos Biotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Shares | ||||||||
| O Shares | ||||||||
| A Shares | 400 | $7.259882 | $455.56 | $455.56 | 1x | $455.56 | 1.78% | |
| O Shares | 6,579 | $7.259882 |
Igyxos Biotherapeutics Comparisons
Industry
Financing
Details
Igyxos Biotherapeutics Competitors (15)
One of Igyxos Biotherapeutics’s 15 competitors is Prelude Fertility, a Private Equity-Backed company based in Franklin, TN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Prelude Fertility | Private Equity-Backed | Franklin, TN | ||||
| ReproSource | Formerly VC-backed | Marlborough, MA | ||||
| Evofem Biosciences | Formerly VC-backed | San Diego, CA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Parexel International | Private Equity-Backed | Durham, NC |
Igyxos Biotherapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Igyxos Biotherapeutics Patents
Igyxos Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10703815-B2 | Ligands that potentiate the bioactivity of gonadotropins | Active | 10-Sep-2014 | ||
| ES-2845674-T3 | Ligands that enhance the bioactivity of gonadotropins | Active | 10-Sep-2014 | ||
| EP-3191515-A1 | Ligands that potentiate the bioactivity of gonadotropins | Active | 10-Sep-2014 | ||
| EP-3191515-B1 | Ligands that potentiate the bioactivity of gonadotropins | Active | 10-Sep-2014 | ||
| CA-2960120-A1 | Ligands that potentiate the bioactivity of gonadotropins | Active | 10-Sep-2014 | C07K16/26 |
Igyxos Biotherapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Igyxos Biotherapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Create Impact Ventures | Impact Investing | Minority | ||
| UI Investissement | PE/Buyout | Minority | ||
| Apicap | PE/Buyout | Minority | ||
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| Centre Capital Développement | Venture Capital | Minority |
Igyxos Biotherapeutics FAQs
-
When was Igyxos Biotherapeutics founded?
Igyxos Biotherapeutics was founded in 2017.
-
Where is Igyxos Biotherapeutics headquartered?
Igyxos Biotherapeutics is headquartered in Nouzilly, France.
-
What is the size of Igyxos Biotherapeutics?
Igyxos Biotherapeutics has 9 total employees.
-
What industry is Igyxos Biotherapeutics in?
Igyxos Biotherapeutics’s primary industry is Drug Discovery.
-
Is Igyxos Biotherapeutics a private or public company?
Igyxos Biotherapeutics is a Private company.
-
What is Igyxos Biotherapeutics’s current revenue?
The current revenue for Igyxos Biotherapeutics is .
-
How much funding has Igyxos Biotherapeutics raised over time?
Igyxos Biotherapeutics has raised $15.6M.
-
Who are Igyxos Biotherapeutics’s investors?
Create Impact Ventures, UI Investissement, Apicap, Bpifrance, and Centre Capital Développement are 5 of 9 investors who have invested in Igyxos Biotherapeutics.
-
Who are Igyxos Biotherapeutics’s competitors?
Prelude Fertility, ReproSource, Evofem Biosciences, Merck & Co., and Parexel International are some of the 15 competitors of Igyxos Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
